Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here. 		You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
TOP SEARCHES: OCT // Canaloplasty // AMD
In this issue
• Lucentis and Avastin
• Alcon v Novartis struggle
• Gene therapy
• Long-sighted gene
• Pfizer award
• Trauma training
• Glaucoma award
Survey

Clear Lens Extraction: Is it ethical?
Novartis

Yes 49%
No 51%

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Pamela Brook, editor.

Click here to contact Neil Hanley, sales manager.
FEBRUARY 10, 2010


Kaiser study results on ranibizumab and bevacizumab
A Kaiser Permanents Southern California study published in this month’s Ophthalmology , the journal of the American Academy of Ophthalmology, compares ranibizumab (Lucentis) and bevacizumab (Avastin) and found them to be equally effective in halting vision loss. More...
Independent directors fight back as Novartis seeks control of Alcon
Novartis continues to plan to assume complete control over Alcon Laboratories Inc. in a two-step process that some analysts and some members of Alcon’s board of directors are challenging for its fairness under Swiss and US merger laws. More...
Gene genie for AMD and RP?
Retinitis pigmentosa and AMD may be the beneficiaries of a new tool for gene therapy that significantly increases gene delivery to cells in the retina. More...
Gene associated with long-sightedness discovered down under
Australia’s Centre for Eye Research has discovered a hepatocyte growth factor (HGF) gene, which it hopes will provide important insights into biological mechanisms involved in ocular development. More...
Pfizer CEO receives award
Pfizer’s CEO, Jeffrey Kindler has received the 2010 Catalyst Award, the Glaucoma Research Foundation’s highest honour, acknowledging his role in sustaining innovative research and education. More...
International oculoplastic reconstruction and trauma surgery
An international course on ophthalmic and oculoplastic reconstruction and trauma surgery will be taking place in Vienna from April 15-17 at the Vienna General Hospital/Neurosurgical Laboratory. More...
Innovative glaucoma research award
The Glaucoma Research Foundation (GRF) awarded the 2010 Shaffer Prize for Innovative Glaucoma Research to Kate Keller, PhD. Dr Keller is Research Assistant Professor, Department of Ophthalmology at Casey Eye Institute in Portland, Oregon. More...

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail at Advanstar Communications, Advanstar House, Park West, Sealand Road, Chester, CH1 4RN, UK.